Monthwise SARS CoV-2 mutation statistics
| Position | Mutation | Clade |
|---|---|---|
| 817 | nsp3:Y817-; | CL-5; |
| 828 | nsp3:Y828-; | CL-3b; |
| 828 | nsp3:Y828M; | CL-3b; |
| 840 | nsp3:Y840-; | CL-3e; |
| 857 | nsp3:Y857-; | CL-3b; |
| 857 | nsp3:Y857C; | CL-3a; |
| 87 | nsp3:Y87-; | CL-3e; |
| 88 | nsp3:Y88-; | CL-3b;CL-3c;CL-3e;CL-3f; |
| 881 | nsp3:Y881-; | CL-1b;CL-3e; |
| 882 | nsp3:Y882-; | CL-3b;CL-3e;CL-3f; |
| 88 | nsp3:Y88C; | CL-3b; |
| 899 | nsp3:Y899-; | CL-3b; |
| 899 | nsp3:Y899F; | CL-3a;CL-3c; |
| 916 | nsp3:Y916-; | CL-3d; |
| 952 | nsp3:Y952-; | CL-3e; |
| 952 | nsp3:Y952H; | CL-3d;CL-3e; |
| 996 | nsp3:Y996C; | CL-3b;CL-3e; |
| 146 | nsp4:A146-; | CL-3e; |
| 146 | nsp4:A146T; | CL-3c;CL-3e; |
| 153 | nsp4:A153T; | CL-3b; |
| 154 | nsp4:A154-; | CL-3b; |
| 162 | nsp4:A162-; | CL-3e; |
| 181 | nsp4:A181-; | CL-3b; |
| 181 | nsp4:A181S; | CL-3e; |
| 21 | nsp4:A21T; | CL-3d;CL-3f; |
| 21 | nsp4:A21V; | CL-3d;CL-3e; |
| 231 | nsp4:A231-; | CL-2;CL-3b;CL-3e;CL-3f; |
| 231 | nsp4:A231F; | CL-3e; |
| 260 | nsp4:A260S; | CL-3c; |
| 282 | nsp4:A282T; | CL-3b;CL-3d; |
| 282 | nsp4:A282V; | CL-3e; |
| 286 | nsp4:A286-; | CL-3e; |
| 291 | nsp4:A291-; | CL-3f; |
| 298 | nsp4:A298-; | CL-3d; |
| 298 | nsp4:A298T; | CL-3b; |
| 298 | nsp4:A298V; | CL-1a;CL-3e; |
| 307 | nsp4:A307T; | CL-3d;CL-3e;CL-3f; |
| 316 | nsp4:A316V; | CL-3e; |
| 361 | nsp4:A361-; | CL-1b; |
| 380 | nsp4:A380-; | CL-3a;CL-3c;CL-3f; |
| 380 | nsp4:A380T; | CL-3c; |
| 415 | nsp4:A415-; | CL-3b; |
| 415 | nsp4:A415V; | CL-3f; |
| 446 | nsp4:A446-; | CL-3a;CL-3b;CL-3d;CL-3e;CL-3f;CL-5; |
| 446 | nsp4:A446S; | CL-2;CL-3b;CL-3e;CL-3f; |
| 446 | nsp4:A446T; | CL-3b; |
| 457 | nsp4:A457-; | CL-3b;CL-3e; |
| 457 | nsp4:A457E; | CL-5; |
| 457 | nsp4:A457P; | CL-1b; |
| 457 | nsp4:A457T; | CL-1a;CL-3b; |
Page 310 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com